• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KLF5和NFYA因子作为前列腺癌细胞代谢的新型调节因子。

KLF5 and NFYA factors as novel regulators of prostate cancer cell metabolism.

作者信息

Poluri Raghavendra T K, Paquette Virginie, Allain Éric P, Lafront Camille, Joly-Beauparlant Charles, Weidmann Cindy, Droit Arnaud, Guillemette Chantal, Pelletier Martin, Audet-Walsh Étienne

机构信息

Département de médecine moléculaire, Faculté de médecine, Axe Endocrinologie - Néphrologie du Centre de recherche Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, et Centre de recherche sur le cancer - Université Laval, Québec, Canada.

Laboratoire de pharmacogénomique, Centre de recherche CHU de Québec - Université Laval et Faculté de Pharmacie, Université Laval, Centre de recherche sur le cancer - Université Laval, Québec, Canada.

出版信息

Endocr Relat Cancer. 2021 Apr;28(4):257-271. doi: 10.1530/ERC-20-0504.

DOI:10.1530/ERC-20-0504
PMID:33690159
Abstract

Prostate cancer (PCa) cells rely on the androgen receptor (AR) signaling axis to reprogram metabolism to sustain aberrant proliferation. Whether additional transcription factors participate to this reprogramming remains mostly unknown. To identify such factors, DNA motif analyses were performed in the promoter and regulatory regions of genes sensitive to androgens in PCa cells. These analyses identified two transcription factors, KLF5 and NFYA, as possibly associated with PCa cell metabolism. In clinical datasets, KLF5 and NFYA expression levels were associated with disease aggressiveness, being significantly decreased and increased, respectively, during PCa progression. Their expression was next investigated by qPCR and Western blot in human PCa cell models, revealing a positive regulation of KLF5 by androgens and a correlation between NFYA and AR protein expression status. siRNA-mediated knockdown of KLF5 increased human PCa cell proliferation rate in AR-positive cell models, suggesting a tumor suppressor function. Live-cell metabolic assays showed that knockdown of KLF5 promoted mitochondrial respiration, a key metabolic pathway associated with PCa progression. The opposite was observed for knockdown of NFYA regarding proliferation and respiration. RNA-seq analyses following the knockdown of either KLF5 and NFYA confirmed that both factors regulated distinct metabolic gene signatures, as well as other gene signatures, explaining their differential impact on PCa cell proliferation and metabolism. Overall, our findings identify KLF5 and NFYA as novel regulators of PCa cell metabolism.

摘要

前列腺癌细胞依赖雄激素受体(AR)信号轴来重新编程代谢,以维持异常增殖。是否有其他转录因子参与这种重新编程大多仍不清楚。为了确定这些因子,对前列腺癌细胞中对雄激素敏感的基因的启动子和调控区域进行了DNA基序分析。这些分析确定了两个转录因子,即KLF5和NFYA,可能与前列腺癌细胞代谢有关。在临床数据集中,KLF5和NFYA的表达水平与疾病侵袭性相关,在前列腺癌进展过程中分别显著降低和升高。接下来,通过qPCR和蛋白质免疫印迹在人前列腺癌细胞模型中研究它们的表达,结果显示雄激素对KLF5有正向调节作用,且NFYA与AR蛋白表达状态之间存在相关性。在AR阳性细胞模型中,siRNA介导的KLF5敲低增加了人前列腺癌细胞的增殖率,表明其具有肿瘤抑制功能。活细胞代谢分析表明,KLF5敲低促进了线粒体呼吸,这是与前列腺癌进展相关的关键代谢途径。对于NFYA敲低后的增殖和呼吸情况则观察到相反的结果。KLF5和NFYA敲低后的RNA测序分析证实,这两个因子都调节不同的代谢基因特征以及其他基因特征,这解释了它们对前列腺癌细胞增殖和代谢的不同影响。总体而言,我们的研究结果确定KLF5和NFYA是前列腺癌细胞代谢的新调节因子。

相似文献

1
KLF5 and NFYA factors as novel regulators of prostate cancer cell metabolism.KLF5和NFYA因子作为前列腺癌细胞代谢的新型调节因子。
Endocr Relat Cancer. 2021 Apr;28(4):257-271. doi: 10.1530/ERC-20-0504.
2
Upregulation of MicroRNA-21 promotes tumorigenesis of prostate cancer cells by targeting KLF5.MicroRNA-21 的上调通过靶向 KLF5 促进前列腺癌细胞的肿瘤发生。
Cancer Biol Ther. 2019;20(8):1149-1161. doi: 10.1080/15384047.2019.1599659. Epub 2019 Apr 19.
3
Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro.雄激素诱导Kruppel样因子5表达导致前列腺癌细胞在体外CXCR4依赖性迁移增加。
Mol Endocrinol. 2009 Sep;23(9):1385-96. doi: 10.1210/me.2009-0010. Epub 2009 May 21.
4
Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer.核 mTOR 作为雄激素信号通路在前列腺癌中的转录整合因子。
Genes Dev. 2017 Jun 15;31(12):1228-1242. doi: 10.1101/gad.299958.117. Epub 2017 Jul 19.
5
circCRKL suppresses the progression of prostate cancer cells by regulating the miR-141/KLF5 axis.环状 RNA 细胞周期调节激酶样蛋白(circCRKL)通过调控微小 RNA-141/富含赖氨酸的分裂增强因子 5(miR-141/KLF5)轴抑制前列腺癌细胞的进展。
Pathol Res Pract. 2020 Nov;216(11):153182. doi: 10.1016/j.prp.2020.153182. Epub 2020 Aug 23.
6
A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling.一种激素依赖性反馈回路通过限制MID1来控制雄激素受体水平,MID1是一种新型的翻译增强剂和致癌信号传导的促进剂。
Mol Cancer. 2014 Jun 9;13:146. doi: 10.1186/1476-4598-13-146.
7
Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.Gli2 共激活野生型和天然截断雄激素受体的决定因素。
Prostate. 2014 Oct;74(14):1400-10. doi: 10.1002/pros.22855. Epub 2014 Aug 11.
8
RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.RhoA作为前列腺癌细胞中临床相关雄激素作用的介质。
Mol Endocrinol. 2012 May;26(5):716-35. doi: 10.1210/me.2011-1130. Epub 2012 Mar 28.
9
Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.雌激素诱导雄激素抑制的SOX4表达以促进前列腺癌细胞的进展。
Prostate. 2015 Sep;75(13):1363-75. doi: 10.1002/pros.23017. Epub 2015 May 27.
10
KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.KLF5增强前列腺癌细胞中雄激素依赖性脂肪酸合酶诱导过程中的SREBP-1活性。
Biochem J. 2009 Jan 1;417(1):313-22. doi: 10.1042/BJ20080762.

引用本文的文献

1
RNA-Seq Uncovers Association of Endocrine-Disrupting Chemicals with Hub Genes and Transcription Factors in Aggressive Prostate Cancer.RNA测序揭示内分泌干扰化学物质与侵袭性前列腺癌中的枢纽基因和转录因子的关联。
Int J Mol Sci. 2025 Jun 6;26(12):5463. doi: 10.3390/ijms26125463.
2
Prostate cancer exploits BRD9-driven metabolic reprogramming to shape the aggressive phenotype.前列腺癌利用由BRD9驱动的代谢重编程来塑造侵袭性表型。
Cell Death Dis. 2025 Apr 22;16(1):326. doi: 10.1038/s41419-025-07561-9.
3
NFYA-mediated promotion of castration-resistant prostate cancer progression through EGR4 regulation.
NFYA通过调控EGR4促进去势抵抗性前列腺癌进展。
Discov Oncol. 2024 Oct 5;15(1):528. doi: 10.1007/s12672-024-01392-4.
4
Transcription factor NFYa controls cardiomyocyte metabolism and proliferation during mouse fetal heart development.转录因子 NFYa 在小鼠胎儿心脏发育过程中控制心肌细胞代谢和增殖。
Dev Cell. 2023 Dec 18;58(24):2867-2880.e7. doi: 10.1016/j.devcel.2023.10.012. Epub 2023 Nov 15.
5
Uncharacterized Proteins CxORFx: Subinteractome Analysis and Prognostic Significance in Cancers.未鉴定蛋白 CxORFx:在癌症中的亚相互作用组分析和预后意义。
Int J Mol Sci. 2023 Jun 15;24(12):10190. doi: 10.3390/ijms241210190.
6
Critical role of antioxidant programs in enzalutamide-resistant prostate cancer.抗氧化方案在恩杂鲁胺耐药前列腺癌中的关键作用。
Oncogene. 2023 Jul;42(30):2347-2359. doi: 10.1038/s41388-023-02756-w. Epub 2023 Jun 24.
7
Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer.异柠檬酸脱氢酶 1 维持着一种杂交的细胞质-线粒体三羧酸循环,可作为前列腺癌治疗的靶点。
Mol Oncol. 2023 Oct;17(10):2109-2125. doi: 10.1002/1878-0261.13441. Epub 2023 Jul 19.
8
New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy.在癌症发病机制、干性和治疗中对 KLFs 和 SOXs 的新认识。
Semin Cancer Biol. 2023 May;90:29-44. doi: 10.1016/j.semcancer.2023.02.003. Epub 2023 Feb 15.
9
NF-YAl drives EMT in Claudin tumours.NF-YA1 驱动 Claudin 肿瘤中的 EMT。
Cell Death Dis. 2023 Jan 28;14(1):65. doi: 10.1038/s41419-023-05591-9.
10
NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma.NFYAv1 是一种与肝癌预后不良相关的肿瘤促进转录本。
Med Sci Monit. 2023 Jan 21;29:e938410. doi: 10.12659/MSM.938410.